Dr. Bollard received her medical degree at the University of Otago in Dunedin, New Zealand. She is board certified both in pediatrics and hematology. In August 2013, she was recruited from Baylor College of Medicine to Washington, DC, to develop a novel cell therapies program at Children’s National Hospital and George Washington University. She is currently the Bosworth Chair for Cancer Biology, Director of the Center for Cancer and Immunology Research at Children’s National Hospital. She is a Professor of Pediatrics and the Associate Center Director for Translational Research and Innovation at the GW Cancer Center. Dr. Bollard is a past president of the International Society for Cellular Therapy, and the current President of the Foundation for the Accreditation of Cellular Therapy. She previously served on the Cellular, Tissues, and Gene Therapies Advisory Committee of the FDA. She is currently Editor in Chief of Blood Advances. She has >250 peer reviewed publications and has been independently NIH funded for over 15 years. Her bench and translational research focuses on the development of novel cell therapies for cancer and virus-associated diseases.